2018
DOI: 10.21518/2079-701x-2018-12-106-110
|View full text |Cite
|
Sign up to set email alerts
|

Efficacy, safety and immunogenicity of a trivalent inactivated split influenza vaccine in patients with rheumatic diseases

Abstract: The aim of the study was to study the efficacy, safety and immunogenicity of trivalent split influenza vaccine in patients with rheumatoid arthritis (RA), ankylosing spondylitis (AS), systemic scleroderma (SSD). Material and methods. Ninety three patients were enrolled in the study, including 52 patients with RA, 34 with AS, 7 with SSD, and also 40 persons without rheumatic diseases (RD) (control group). At the time of enrolment, all patients received RD drug therapy. The duration of RD was from 2 months up to… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
5

Relationship

3
2

Authors

Journals

citations
Cited by 8 publications
references
References 24 publications
(21 reference statements)
0
0
0
Order By: Relevance